title: Specific in vivo knockdown of protein function by intrabodies.
abstract: Intracellular antibodies (intrabodies) are recombinant antibody fragments that bind to target proteins expressed inside of the same living cell producing the antibodies. The molecules are commonly used to study the function of the target proteins (i.e., their antigens). The intrabody technology is an attractive alternative to the generation of gene-targeted knockout animals, and complements knockdown techniques such as RNAi, miRNA and small molecule inhibitors, by-passing various limitations and disadvantages of these methods. The advantages of intrabodies include very high specificity for the target, the possibility to knock down several protein isoforms by one intrabody and targeting of specific splice variants or even post-translational modifications. Different types of intrabodies must be designed to target proteins at different locations, typically either in the cytoplasm, in the nucleus or in the endoplasmic reticulum (ER). Most straightforward is the use of intrabodies retained in the ER (ER intrabodies) to knock down the function of proteins passing the ER, which disturbs the function of members of the membrane or plasma proteomes. More effort is needed to functionally knock down cytoplasmic or nuclear proteins because in this case antibodies need to provide an inhibitory effect and must be able to fold in the reducing milieu of the cytoplasm. In this review, we present a broad overview of intrabody technology, as well as applications both of ER and cytoplasmic intrabodies, which have yielded valuable insights in the biology of many targets relevant for drug development, including α-synuclein, TAU, BCR-ABL, ErbB-2, EGFR, HIV gp120, CCR5, IL-2, IL-6, β-amyloid protein and p75NTR. Strategies for the generation of intrabodies and various designs of their applications are also reviewed.
authors.affiliation: a Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics ; Braunschweig , Germany.
authors.forename: Andrea L J
authors.initials: AL
authors.lastname: Marschall
authors.affiliation: a Technische Universität Braunschweig, Institute of Biochemistry, Biotechnology and Bioinformatics ; Braunschweig , Germany.
authors.forename: Stefan
authors.initials: S
authors.lastname: Dübel
authors.affiliation: b Helmholtz Centre for Infection Research, Recombinant Protein Expression/Intrabody Unit, Helmholtz Centre for Infection Research ; Braunschweig , Germany.
authors.forename: Thomas
authors.initials: T
authors.lastname: Böldicke
mesh_terms: D000818:Animals; D000906:Antibodies / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D002467:Cell Nucleus / Q000276:immunology / Q000378:metabolism; D003593:Cytoplasm / Q000276:immunology / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000276:immunology / Q000378:metabolism; D055785:Gene Knockdown Techniques / Q000379:methods*; D006801:Humans; D042541:Intracellular Space / Q000276:immunology* / Q000378:metabolism; D018448:Models, Immunological; D020543:Proteome / Q000276:immunology*
chemical_list: D000906:Antibodies; D020543:Proteome
keywords: KDEL; endoplasmic reticulum; inhibitor; intrabody; knockdown; knockout